🔗 Share this article

Chancellor Reeves has stated she is preparing "specific steps to address cost of living issues" in the forthcoming Budget.

During an interview with media outlets, she noted that lowering price rises is a joint duty of both the government and the Bank of England.

The United Kingdom's price growth is projected to be the most elevated among the Group of Seven industrialized countries this year and the following year.

Potential Utility Bill Measures

It is understood the administration could take action to bring down utility costs, for instance by cutting the current 5% level of value-added tax charged on energy.

An additional option is to cut some of the regulatory levies presently included in household expenses.

Budgetary Limitations and Analyst Predictions

The administration will receive the next draft from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for these measures.

The consensus from the majority of economists is that the Chancellor will have to introduce higher taxes or budget cuts in order to meet her self-imposed borrowing rules.

Earlier on the same day, estimates suggested there was a £22 billion deficit for the chancellor to address, which is at the more modest range of forecasts.

"There's a shared job between the Bank of England and the government to bear down further on some of the sources of inflation," the Chancellor informed the BBC in Washington, at the conferences of the International Monetary Fund and World Bank.

Tax Pledges and Global Issues

While much of the attention has been on probable tax rises, the chancellor said the latest information from the OBR had not altered her commitment to manifesto promises not to increase rates on income tax, VAT or social security contributions.

She attributed an "uncertain world" with growing international and trade tensions for the fiscal tax moves, probably to be targeted on those "with the broadest shoulders."

International Trade Disputes

Commenting on worries about the UK's economic relations with the Asian nation she said: "The UK's national security always take priority."

Recent announcement by Chinese authorities to tighten export controls on critical minerals and other materials that are essential for advanced tech production led American leader Donald Trump to threaten an extra 100% tariff on goods from China, raising the risk of an full-scale trade war between the two largest economies.

The American finance chief labeled China's action "economic coercion" and "a global supply chain control attempt."

Questioned on considering the American proposal to join its dispute with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese measures and called on the Chinese government "to avoid restrictions and restrict access."

She said the action was "bad for the global economy and causes additional challenges."

"It is my opinion there are sectors where we should challenge Chinese policies, but there are also significant chances to sell into Chinese markets, including financial services and other areas of the economy. We've got to maintain that balance appropriate."

The Treasury chief also affirmed she was cooperating with other major economies "on our own critical minerals plan, so that we are more independent."

NHS Medicine Costs and Investment

The Chancellor also acknowledged that the price the National Health Service spends on pharmaceuticals could increase as a result of current talks with the US government and its pharmaceutical firms, in return for reduced taxes and capital.

A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either pausing or scrapping investments in the United Kingdom, with some attributing the low prices they are receiving.

Last month, the government science advisor said the cost the NHS pays for medicines would have to go up to stop companies and drug research funding leaving the United Kingdom.

The Chancellor stated to media: "We have seen as a result of the payment system, that clinical trials, recent pharmaceuticals have not been provided in the UK in the extent that they are in other continental states."

"The objective is to ensure that patients getting treatment from the National Health Service are can access the finest essential medicines in the globe. And so we are examining all of that, and... aiming to obtain more capital into Britain."